723 related articles for article (PubMed ID: 10408394)
1. Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice.
Brasseur N; Ouellet R; La Madeleine C; van Lier JE
Br J Cancer; 1999 Jul; 80(10):1533-41. PubMed ID: 10408394
[TBL] [Abstract][Full Text] [Related]
2. Targeting of aluminum (III) phthalocyanine tetrasulfonate by use of internalizing monoclonal antibodies: improved efficacy in photodynamic therapy.
Vrouenraets MB; Visser GW; Stigter M; Oppelaar H; Snow GB; van Dongen GA
Cancer Res; 2001 Mar; 61(5):1970-5. PubMed ID: 11280754
[TBL] [Abstract][Full Text] [Related]
3. Distribution and photodynamic effect of zinc phthalocyanine disulfonate in nude mice bearing mammary carcinoma.
Mosa M; Zitko M; Poucková P
Neoplasma; 1997; 44(3):178-83. PubMed ID: 9372860
[TBL] [Abstract][Full Text] [Related]
4. Topical photodynamic therapy of murine non-melanoma skin carcinomas with aluminum phthalocyanine chloride and a diode laser: pharmacokinetics, tumor response and cosmetic outcomes.
Kyriazi M; Alexandratou E; Yova D; Rallis M; Trebst T
Photodermatol Photoimmunol Photomed; 2008 Apr; 24(2):87-94. PubMed ID: 18353089
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyphthalocyanines as potential photodynamic agents for cancer therapy.
Hu M; Brasseur N; Yildiz SZ; van Lier JE; Leznoff CC
J Med Chem; 1998 May; 41(11):1789-802. PubMed ID: 9599230
[TBL] [Abstract][Full Text] [Related]
6. Hexadecafluorinated zinc phthalocyanine: photodynamic properties against the EMT-6 tumour in mice and pharmacokinetics using 65Zn as a radiotracer.
Boyle RW; Rousseau J; Kudrevich SV; Obochi M; van Lier JE
Br J Cancer; 1996 Jan; 73(1):49-53. PubMed ID: 8554982
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of mono-substituted trisulfonated porphyrazines for the photodynamic therapy (PDT) of cancer.
Cauchon N; Ali H; Hasséssian HM; van Lier JE
Photochem Photobiol Sci; 2010 Mar; 9(3):331-41. PubMed ID: 20221459
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.
Megerian CA; Zaidi SI; Sprecher RC; Setrakian S; Stepnick DW; Oleinick NL; Mukhtar H
Laryngoscope; 1993 Sep; 103(9):967-75. PubMed ID: 8361317
[TBL] [Abstract][Full Text] [Related]
9. Correlation of distribution of sulphonated aluminium phthalocyanines with their photodynamic effect in tumour and skin of mice bearing CaD2 mammary carcinoma.
Peng Q; Moan J
Br J Cancer; 1995 Sep; 72(3):565-74. PubMed ID: 7669563
[TBL] [Abstract][Full Text] [Related]
10. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
Chan WS; Brasseur N; La Madeleine C; van Lier JE
Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
12. The in vivo efficacy of phthalocyanine-nanoparticle conjugates for the photodynamic therapy of amelanotic melanoma.
Camerin M; Magaraggia M; Soncin M; Jori G; Moreno M; Chambrier I; Cook MJ; Russell DA
Eur J Cancer; 2010 Jul; 46(10):1910-8. PubMed ID: 20356732
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution and phototherapeutic properties of Zinc (II) 2,9,16,23-tetrakis (methoxy) phthalocyanine in vivo.
Yslas EI; Prucca C; Romanini S; Durantini EN; Bertuzzi M; Rivarola V
Photodiagnosis Photodyn Ther; 2009 Mar; 6(1):62-70. PubMed ID: 19447373
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic, toxicological and phototherapeutic studies of phthalocyanine ZnPcCF3.
Milla LN; Yslas EI; Cabral A; Durantini EN; Romanini S; Rivarola V; Bertuzzi M
Biomed Pharmacother; 2009 Mar; 63(3):209-15. PubMed ID: 18599256
[TBL] [Abstract][Full Text] [Related]
15. Enhanced photodynamic destruction of a transplantable fibrosarcoma using photochemical internalisation of gelonin.
Dietze A; Peng Q; Selbo PK; Kaalhus O; Müller C; Bown S; Berg K
Br J Cancer; 2005 Jun; 92(11):2004-9. PubMed ID: 15886704
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and mechanism of aluminium phthalocyanine and its sulphonated derivatives mediated photodynamic therapy on murine tumours.
Chan WS; Brasseur N; La Madeleine C; Ouellet R; van Lier JE
Eur J Cancer; 1997 Oct; 33(11):1855-9. PubMed ID: 9470846
[TBL] [Abstract][Full Text] [Related]
17. Delivery of a hydrophobic phthalocyanine photosensitizer using PEGylated gold nanoparticle conjugates for the in vivo photodynamic therapy of amelanotic melanoma.
Camerin M; Moreno M; Marín MJ; Schofield CL; Chambrier I; Cook MJ; Coppellotti O; Jori G; Russell DA
Photochem Photobiol Sci; 2016 May; 15(5):618-25. PubMed ID: 27064601
[TBL] [Abstract][Full Text] [Related]
18. Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake.
Roberts WG; Hasan T
Cancer Res; 1993 Jan; 53(1):153-7. PubMed ID: 8416739
[TBL] [Abstract][Full Text] [Related]
19. Biological activities of phthalocyanines. XVII histopathologic evidence for different mechanisms of EMT-6 tumor necrosis induced by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin.
Margaron P; Madarnas P; Quellet R; Van Lier JE
Anticancer Res; 1996; 16(2):613-20. PubMed ID: 8687105
[TBL] [Abstract][Full Text] [Related]
20. Tissue uptake, distribution, and potency of the photoactivatable dye chloroaluminum sulfonated phthalocyanine in mice bearing transplantable tumors.
Chan WS; Marshall JF; Lam GY; Hart IR
Cancer Res; 1988 Jun; 48(11):3040-4. PubMed ID: 3284641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
